Faisal Zain has spent years at the intersection of medical innovation and patient care, focusing on the manufacturing of life-saving diagnostic tools and treatment devices. His perspective on the current friction between insurance protocols and medical technology offers a unique window into why the healthcare system feels increasingly broken for patients despite high-level reform efforts. With extensive experience in how medical devices are integrated into clinical workflows, he understands the technical and administrative barriers that often stand between a doctor’s recommendation and a patient’s recovery.
In this conversation, we examine the fallout from a high-profile industry pledge aimed at reforming the prior authorization process, which has long been a source of frustration for both clinicians and those seeking care. We explore the persistence of analog systems like fax machines in a digital age, the reality behind reported statistical improvements in claim approvals, and the legal loopholes that allow insurers to bypass promises of continuous care. The discussion also touches on the role of emerging technology in generating denials and the lack of federal oversight in holding major insurance carriers accountable to their voluntary commitments.
The healthcare industry has seen a major push toward streamlining the prior authorization process, yet many practitioners and patients claim the situation is worse than ever. Based on the recent data, how do you reconcile the industry’s reported improvements with the daily reality of those seeking medical care?
The discrepancy between the data provided by insurance trade groups and the lived experience of patients is staggering. According to AHIP, the health insurance industry trade group, health plans have successfully eliminated approximately 6.5 million prior authorizations since the announcement of the voluntary reform pledge. This figure represents an 11% reduction in these administrative hurdles, which the industry points to as significant progress in reducing barriers to doctor-recommended care. However, critics and patient advocates frequently describe these efforts as “performative” and suggest the numbers hide a much darker nuance. While low-cost or routine services might see fewer hurdles, patients requiring the most expensive and critical interventions, such as complex cancer treatments, continue to face disproportionate denials. The reality on the ground is that medical professionals are still navigating a system that feels designed to delay, even as corporate reports suggest the burden is lifting.
One of the most surprising aspects of modern healthcare is the continued reliance on outdated communication methods like fax machines for critical approvals. Why has the transition to standardized electronic submissions proven so difficult for even the largest insurance carriers?
It is a profound irony that in an era of advanced diagnostics and robotic surgery, more than 50% of prior authorizations are still paper-based and processed via phone or fax machine. The 2024 industry pledge included a specific promise to adopt new technology to standardize electronic submissions, with a goal of being fully operational by January 1, 2027. However, the momentum shifted significantly in April when eight major insurers, including Alignment Health Plan, Medica, and Independent Health, declined to sign a technology update related to these initiatives. These companies often cite technical and operational hurdles, or concerns about transferring confidential member health information through non-standardized third-party processes, as reasons for their hesitation. For a parent like Betsy Adler, this technical lag meant her critically ill newborn’s referrals were lost because an insurer’s fax machine was down, forcing a family already in crisis to wage a bureaucratic war. This persistent reliance on analog systems acts as a functional bottleneck that serves the insurer’s bottom line while leaving patients in a state of dangerous uncertainty.
The concept of “continuity of care” was a cornerstone of the reform pledge, specifically promising a 90-day grace period for patients switching plans. Why are we seeing families still facing thousands of dollars in unexpected costs despite these explicit promises?
The 90-day grace period was intended to protect patients from losing access to authorized treatments when they change insurance providers, but the implementation has been riddled with loopholes. While insurers pledged to honor authorizations from previous plans, the wording often leaves them room to ignore the previous plan’s network parameters. We see this play out in heartbreaking ways, such as a family in Minnesota who accrued over $4,000 in out-of-network charges within weeks of their daughter’s birth because their new insurer, Medica, did not honor the hospital’s status from their previous plan. Even when a mother checks the provider lists and human resources documentation beforehand, the “continuity” often only applies to the medical necessity of the procedure, not the financial agreement regarding which doctors are covered. This creates a trap for the most vulnerable patients who, believing they are protected by a public pledge, find themselves facing insurmountable debt at the exact moment they should be focused on recovery.
There is a growing concern regarding “retroactive denials,” where care is initially approved but payment is withheld after the service is rendered. How does this practice undermine the trust in the medical system, and what does it reveal about the limitations of the current reform pledge?
The practice of retroactive denial is perhaps the most damaging tactic used by insurers today because it essentially renders the prior authorization process meaningless for the patient. Even when a patient receives an “approval” letter, those documents often contain fine print stating that authorization is not a guarantee of claim payment. For example, a patient in New York received a bill for $12,000 for substance abuse treatment months after her insurer had authorized her admission, under the claim that the medical record did not sufficiently support what was billed. These “back-end” denials allow insurance companies to report a reduction in initial prior authorization hurdles while still exercising the power to withhold payment later. It forces patients into a defensive position where they are held responsible for five-figure bills for care they were told was covered, leading many to lose faith in the entire administrative structure of American medicine.
The federal government originally suggested that there would be public dashboards and high levels of accountability for insurers who signed this pledge. What has happened to those oversight mechanisms, and how is the lack of transparency affecting patient advocacy?
When the pledge was first announced with much fanfare, federal officials like Mehmet Oz spoke about “driving accountability” and “evaluating progress” through public tools that would allow the public to see which companies were falling short. To date, those public dashboards do not exist, and the Department of Health and Human Services has remained largely silent when questioned about the lack of enforcement. Without clear mandates, rules, or standards, researchers point out that insurance companies will naturally prioritize their financial interests over voluntary social contracts. This lack of transparency has led many lawmakers to believe that the industry cannot be trusted to police itself, especially as they suspect insurers are increasingly using artificial intelligence to generate immediate, automated denials. When there is no official federal mechanism to track these behaviors, it becomes nearly impossible for patient advocates or clinicians to push for systemic change, leaving them to fight these battles one individual claim at a time.
What is your forecast for the future of prior authorization reform given the current resistance from major insurance carriers?
I believe we are approaching a breaking point where voluntary pledges will be replaced by strict, bipartisan federal mandates, as the current “performative” nature of these agreements has only deepened public frustration. We are already seeing the House Ways and Means Committee move toward legislation that would force Medicare Advantage plans to report transparent data on denials and grievances, which is a direct response to the failure of industry self-regulation. However, the insurance lobby remains one of the most powerful forces in the country, and they will likely continue to cite operational hurdles and data privacy concerns to delay the transition to a fully electronic, transparent system. In the short term, patients should expect a rise in “stealth” denials—where the initial authorization is easy to obtain, but the retroactive audit becomes much more aggressive. Until there are executive orders or laws with real “teeth” that include financial penalties for non-compliance, the burden of navigating this complex landscape will unfortunately remain on the shoulders of the physicians and the families they serve.
